These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 20173632)
1. Anesthesia for patients with a history of malignant hyperthermia. Wappler F Curr Opin Anaesthesiol; 2010 Jun; 23(3):417-22. PubMed ID: 20173632 [TBL] [Abstract][Full Text] [Related]
3. McArdle's disease and anaesthesia: case reports. Review of potential problems and association with malignant hyperthermia. Bollig G; Mohr S; Raeder J Acta Anaesthesiol Scand; 2005 Sep; 49(8):1077-83. PubMed ID: 16095447 [TBL] [Abstract][Full Text] [Related]
4. Consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients from the European Malignant Hyperthermia Group. Rüffert H; Bastian B; Bendixen D; Girard T; Heiderich S; Hellblom A; Hopkins PM; Johannsen S; Snoeck MM; Urwyler A; Glahn KPE; Br J Anaesth; 2021 Jan; 126(1):120-130. PubMed ID: 33131754 [TBL] [Abstract][Full Text] [Related]
5. Preparation of modern anesthesia workstations for malignant hyperthermia-susceptible patients: a review of past and present practice. Kim TW; Nemergut ME Anesthesiology; 2011 Jan; 114(1):205-12. PubMed ID: 21169802 [TBL] [Abstract][Full Text] [Related]
13. Malignant hyperthermia in the otology patient: the UCLA experience. Wackym PA; Blackwell KE Am J Otol; 1994 May; 15(3):371-5. PubMed ID: 8579142 [TBL] [Abstract][Full Text] [Related]
14. [Diagnosis of malignant hyperthermia susceptibility. 2. Anesthesia for muscle biopsy. Differential diagnosis in negative test results]. Breucking E; Mortier W Anaesthesist; 1993 Oct; 42(10):684-90. PubMed ID: 8250202 [TBL] [Abstract][Full Text] [Related]
15. [Management of a patient with malignant hyperthermia susceptibility during anesthesia and daily living]. Jacquot C; Stieglitz P Ann Fr Anesth Reanim; 1989; 8(5):417-26. PubMed ID: 2697156 [TBL] [Abstract][Full Text] [Related]
16. [Prophylaxis with dantrolene sodium in 2 patients with susceptibility to malignant hyperthermia]. Navas E; Sánchez-Peña J; Gutiérrez-Crespo A Rev Esp Anestesiol Reanim; 1992; 39(5):309-11. PubMed ID: 1410753 [TBL] [Abstract][Full Text] [Related]
17. [The use of subarachnoid bupivacaine analgesia in malignant hyperthermia-susceptible subjects. A clinical case report]. Abballe C; Primieri P; De Cosmo G Minerva Anestesiol; 1993 Jun; 59(6):335-8. PubMed ID: 8414095 [TBL] [Abstract][Full Text] [Related]
18. Malignant hyperthermia susceptibility: anaesthetic implications and risk stratification. Ben Abraham R; Cahana A; Krivosic-Horber RM; Perel A QJM; 1997 Jan; 90(1):13-8. PubMed ID: 9093584 [TBL] [Abstract][Full Text] [Related]
19. Preparation of modern anesthesia workstations for malignant hyperthermia-susceptible patients: when are they really clean? Wappler F Anesthesiology; 2011 Aug; 115(2):434-5; author reply 436-7. PubMed ID: 21791992 [No Abstract] [Full Text] [Related]
20. Dantrolene sodium in the management of patients at risk from malignant hyperthermia. Bronstein SL; Ryan DE; Solomons CC; Mahowald MC J Oral Surg; 1979 Oct; 37(10):719-24. PubMed ID: 289734 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]